• News
  • SAN DIEGO
  • Medical

Illumina links with big pharmas on cancer research

San Diego’s Illumina Inc. (Nasdaq: ILMN) announced Thursday that it has formed collaborative partnerships with three leading pharmaceutical companies to develop a universal next-generation genetic sequencing test system for cancers.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ILMN
164.47
  -0.44  
- 0.27%
1,802,078,000
185.00
80.88

Insider Trade Data

Date Insider Shares Type Value
10/15/2014 Naclerio, Nicholas J 2,000 Sell $295,709
10/14/2014 Stapley, Marc A 1,422 Sell $215,403
10/13/2014 Bradbury, Daniel M 2,100 Sell $319,257
10/13/2014 Bradbury, Daniel M 2,100 Exchange $89,922
10/13/2014 Bradbury, Daniel M 2,100 Sell $319,257

Illumina Inc. Executive(s):

Jay Flatley

  • Chief Executive Officer, President

Similar Companies

NAICS - 334516 - Analytical Laboratory Instrument Manufacturing
SIC - 3826 - LABORATORY ANALYTICAL INSTRUMENTS
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!